
A Joint Venture of Quintiles and Thermo Fisher Scientific
CENDUIT NEWS
November 28, 2011 - Cenduit Continues Expansion with Key Management HiresJanuary 26, 2012 - Cenduit Experts to Present at Clinical Trial Supply Events
January 28, 2010 - Cenduit and invivodata, inc. Align to Integrate Clinical IRT and ePRO Solutions
December 9, 2009 - Cenduit Selects SAP BusinessObjects to Revolutionize Clinical Trial Reporting & Analytics
April 23, 2008 - Executives Join Cenduit’s Team

Return-On-Investment
Once internal business processes and stakeholders needs have been defined and captured as standard IRT requirements, our flexible system can build off of this study template to provide efficient, consistent system builds for similar future studies. This use of the template adds a percentage of savings which is expected or has been seen in other opportunities in which the tactic was implemented.
IRT Custom Xpress uniquely maximizes return-on-investment by reducing timelines, and yielding significant efficiencies in the following areas:
- IRT Custom Xpress increases study accuracy and efficiency
- IRT Custom Xpress implementations are dramatically accelerated from the 8-12 week industry standard to just 4-5 weeks
- Overall study cost reduction via IRT integration with Electronic Data Capture, Clinical Trial Management, and Drug Supply Inventory Management Systems, and Electronic Patient Reported Outcomes of invivodata EPXTM ePro
- Enhances custom reporting and analytics capabilities powered by SAP BusinessObjects
© 2009 Cenduit - A Quintiles and Fisher Clinical Services Company. All rights reserved. Site design: Capstone Design Group | Site Map
